Yubo International Biotech
(OTC) YBGJ
Yubo International Biotech Financials at a Glance
Market Cap
$1.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$134.39K
Net Income (TTM)
-$916.23K
EPS (TTM)
-$0.01
P/E Ratio
-0.96
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Price
$0.01
Volume
30
Open
$0.01
Price
$0.01
Volume
30
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.18
Estimated Earnings Date
Mar 31, 2026
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Price
$0.01
Volume
30
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.18
Estimated Earnings Date
Mar 31, 2026
YBGJ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Yubo International Biotech
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Wang Yang, MBA
Website
www.yubogroup.comHeadquarters
Beijing, BE, CN
YBGJ Financials
Key Financial Metrics (TTM)
Gross Margin
15.83%
Operating Margin
-751.29%
Net Income Margin
-681.76%
Return on Equity
36.96%
Return on Capital
N/A
Return on Assets
-129.07%
Earnings Yield
-1.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
170.42M
Volume
30
Avg. Volume
3.60K
Financials (TTM)
Gross Profit
$21.27K
Operating Income
-$1.01M
EBITDA
-$1.01M
Operating Cash Flow
-$249.39K
Capital Expenditure
$6.18K
Free Cash Flow
-$243.21K
Cash & ST Invst.
$10.38K
Total Debt
$39.22K
Yubo International Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$31.52K
+29.4%
Gross Margin
0.00%
N/A
Market Cap
$1.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$80.29K
N/A
Employees
14
N/A
Net Income
-$272.61K
+37.4%
EBITDA
-$269.28K
+36.3%
Quarterly Fundamentals
Total Cash
$10.38K
+6.2%
Total Debt
$39.22K
-83.1%
Accounts Receivable
$134.22K
-68.5%
Inventory
$24.41K
-34.4%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$39.22K
-80.4%
Return on Assets
-1.29%
N/A
Return on Invested Capital
43.72%
N/A
Free Cash Flow
-$207.16K
+48.0%
Operating Cash Flow
-$207.16K
+47.2%